Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

NCT04492787 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome with Diarrhea

Interventions

DRUG: Changkang Granule
DRUG: Changkang Placebo Granule

Sponsor

Tasly Pharmaceutical Group Co., Ltd